Delivery Order SPE2DB22D1041-SPE2DB25FUAX5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $1,408.53 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for Refresh Plus 0.5% eye drops (30-count unit). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by October 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $2,395.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's existing federal contract vehicle with DLA. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50 unit dose supplies) valued at $1,087.55 under a firm fixed-price contract. This non-set-aside delivery order was awarded on April 30, 2025, with an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count) on September 23, 2025, with a ceiling value of $2,008.77 and a firm fixed price structure. This is a non-set-aside competitive award to be fulfilled at the company's Conshohocken, Pennsylvania location, with completion scheduled for September 24, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,740.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units). Issued on September 16, 2025, with an ultimate completion date of September 17, 2025, this competitively awarded contract required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.92 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 70s, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement portfolio. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,910.27 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50 units). This is a firm fixed price, competitively awarded contract with no set-aside designation, completed on April 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor for federal medical procurement. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (70 count unit dose) on October 16, 2025, with a ceiling value of $1,214.81 and an ultimate completion date of October 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,004.38 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUAX5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,733.81 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including offerings to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/18/25 |